Potential role for ADAM15 in pathological neovascularization in mice

Keisuke Horiuchi, Gisela Weskamp, Lawrence Lum, Hans Peter Hammes, Hui Cai, Thomas A. Brodie, Thomas Ludwig, Riccardo Chiusaroli, Roland Baron, Klaus T. Preissner, Katia Manova, Carl P. Blobel

Research output: Contribution to journalArticle

140 Citations (Scopus)

Abstract

ADAM15 (named for a disintegrin and metalloprotease 15, metargidin) is a membrane-anchored glycoprotein that has been implicated in cell-cell or cell-matrix interactions and in the proteolysis of molecules on the cell surface or extracellular matrix. To characterize the potential roles of ADAM15 during development and in adult mice, we analyzed its expression pattern by mRNA in situ hybridization and generated mice carrying a targeted deletion of ADAM15 (adam15-/- mice). A high level of expression of ADAM15 was found in vascular cells, the endocardium, hypertrophic cells in developing bone, and specific areas of the hippocampus and cerebellum. However, despite the pronounced expression of ADAM15 in these tissues, no major developmental defects or pathological phenotypes were evident in adam15-/- mice. The elevated levels of ADAM15 in endothelial cells prompted an evaluation of its role in neovascularization. In a mouse model for retinopathy of prematurity, adam15-/- mice had a major reduction in neovascularization compared to wild-type controls. Furthermore, the size of tumors resulting from implanted B16F0 mouse melanoma cells was significantly smaller in adam15-/- mice than in wild-type controls. Since ADAM15 does not appear to be required for developmental angiogenesis or for adult homeostasis, it may represent a novel target for the design of inhibitors of pathological neovascularization.

Original languageEnglish
Pages (from-to)5614-5624
Number of pages11
JournalMolecular and Cellular Biology
Volume23
Issue number16
DOIs
Publication statusPublished - 2003 Aug
Externally publishedYes

Fingerprint

Pathologic Neovascularization
Disintegrins
Metalloproteases
Endocardium
Retinopathy of Prematurity
Membrane Glycoproteins
Cell Communication
Cerebellum
Proteolysis
In Situ Hybridization
Extracellular Matrix
Blood Vessels
Melanoma
Hippocampus
Homeostasis
Endothelial Cells
Phenotype
Bone and Bones
Messenger RNA

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cell Biology

Cite this

Horiuchi, K., Weskamp, G., Lum, L., Hammes, H. P., Cai, H., Brodie, T. A., ... Blobel, C. P. (2003). Potential role for ADAM15 in pathological neovascularization in mice. Molecular and Cellular Biology, 23(16), 5614-5624. https://doi.org/10.1128/MCB.23.16.5614-5624.2003

Potential role for ADAM15 in pathological neovascularization in mice. / Horiuchi, Keisuke; Weskamp, Gisela; Lum, Lawrence; Hammes, Hans Peter; Cai, Hui; Brodie, Thomas A.; Ludwig, Thomas; Chiusaroli, Riccardo; Baron, Roland; Preissner, Klaus T.; Manova, Katia; Blobel, Carl P.

In: Molecular and Cellular Biology, Vol. 23, No. 16, 08.2003, p. 5614-5624.

Research output: Contribution to journalArticle

Horiuchi, K, Weskamp, G, Lum, L, Hammes, HP, Cai, H, Brodie, TA, Ludwig, T, Chiusaroli, R, Baron, R, Preissner, KT, Manova, K & Blobel, CP 2003, 'Potential role for ADAM15 in pathological neovascularization in mice', Molecular and Cellular Biology, vol. 23, no. 16, pp. 5614-5624. https://doi.org/10.1128/MCB.23.16.5614-5624.2003
Horiuchi, Keisuke ; Weskamp, Gisela ; Lum, Lawrence ; Hammes, Hans Peter ; Cai, Hui ; Brodie, Thomas A. ; Ludwig, Thomas ; Chiusaroli, Riccardo ; Baron, Roland ; Preissner, Klaus T. ; Manova, Katia ; Blobel, Carl P. / Potential role for ADAM15 in pathological neovascularization in mice. In: Molecular and Cellular Biology. 2003 ; Vol. 23, No. 16. pp. 5614-5624.
@article{1b014b7949df4a37b4fa6c7426d7f1aa,
title = "Potential role for ADAM15 in pathological neovascularization in mice",
abstract = "ADAM15 (named for a disintegrin and metalloprotease 15, metargidin) is a membrane-anchored glycoprotein that has been implicated in cell-cell or cell-matrix interactions and in the proteolysis of molecules on the cell surface or extracellular matrix. To characterize the potential roles of ADAM15 during development and in adult mice, we analyzed its expression pattern by mRNA in situ hybridization and generated mice carrying a targeted deletion of ADAM15 (adam15-/- mice). A high level of expression of ADAM15 was found in vascular cells, the endocardium, hypertrophic cells in developing bone, and specific areas of the hippocampus and cerebellum. However, despite the pronounced expression of ADAM15 in these tissues, no major developmental defects or pathological phenotypes were evident in adam15-/- mice. The elevated levels of ADAM15 in endothelial cells prompted an evaluation of its role in neovascularization. In a mouse model for retinopathy of prematurity, adam15-/- mice had a major reduction in neovascularization compared to wild-type controls. Furthermore, the size of tumors resulting from implanted B16F0 mouse melanoma cells was significantly smaller in adam15-/- mice than in wild-type controls. Since ADAM15 does not appear to be required for developmental angiogenesis or for adult homeostasis, it may represent a novel target for the design of inhibitors of pathological neovascularization.",
author = "Keisuke Horiuchi and Gisela Weskamp and Lawrence Lum and Hammes, {Hans Peter} and Hui Cai and Brodie, {Thomas A.} and Thomas Ludwig and Riccardo Chiusaroli and Roland Baron and Preissner, {Klaus T.} and Katia Manova and Blobel, {Carl P.}",
year = "2003",
month = "8",
doi = "10.1128/MCB.23.16.5614-5624.2003",
language = "English",
volume = "23",
pages = "5614--5624",
journal = "Molecular and Cellular Biology",
issn = "0270-7306",
publisher = "American Society for Microbiology",
number = "16",

}

TY - JOUR

T1 - Potential role for ADAM15 in pathological neovascularization in mice

AU - Horiuchi, Keisuke

AU - Weskamp, Gisela

AU - Lum, Lawrence

AU - Hammes, Hans Peter

AU - Cai, Hui

AU - Brodie, Thomas A.

AU - Ludwig, Thomas

AU - Chiusaroli, Riccardo

AU - Baron, Roland

AU - Preissner, Klaus T.

AU - Manova, Katia

AU - Blobel, Carl P.

PY - 2003/8

Y1 - 2003/8

N2 - ADAM15 (named for a disintegrin and metalloprotease 15, metargidin) is a membrane-anchored glycoprotein that has been implicated in cell-cell or cell-matrix interactions and in the proteolysis of molecules on the cell surface or extracellular matrix. To characterize the potential roles of ADAM15 during development and in adult mice, we analyzed its expression pattern by mRNA in situ hybridization and generated mice carrying a targeted deletion of ADAM15 (adam15-/- mice). A high level of expression of ADAM15 was found in vascular cells, the endocardium, hypertrophic cells in developing bone, and specific areas of the hippocampus and cerebellum. However, despite the pronounced expression of ADAM15 in these tissues, no major developmental defects or pathological phenotypes were evident in adam15-/- mice. The elevated levels of ADAM15 in endothelial cells prompted an evaluation of its role in neovascularization. In a mouse model for retinopathy of prematurity, adam15-/- mice had a major reduction in neovascularization compared to wild-type controls. Furthermore, the size of tumors resulting from implanted B16F0 mouse melanoma cells was significantly smaller in adam15-/- mice than in wild-type controls. Since ADAM15 does not appear to be required for developmental angiogenesis or for adult homeostasis, it may represent a novel target for the design of inhibitors of pathological neovascularization.

AB - ADAM15 (named for a disintegrin and metalloprotease 15, metargidin) is a membrane-anchored glycoprotein that has been implicated in cell-cell or cell-matrix interactions and in the proteolysis of molecules on the cell surface or extracellular matrix. To characterize the potential roles of ADAM15 during development and in adult mice, we analyzed its expression pattern by mRNA in situ hybridization and generated mice carrying a targeted deletion of ADAM15 (adam15-/- mice). A high level of expression of ADAM15 was found in vascular cells, the endocardium, hypertrophic cells in developing bone, and specific areas of the hippocampus and cerebellum. However, despite the pronounced expression of ADAM15 in these tissues, no major developmental defects or pathological phenotypes were evident in adam15-/- mice. The elevated levels of ADAM15 in endothelial cells prompted an evaluation of its role in neovascularization. In a mouse model for retinopathy of prematurity, adam15-/- mice had a major reduction in neovascularization compared to wild-type controls. Furthermore, the size of tumors resulting from implanted B16F0 mouse melanoma cells was significantly smaller in adam15-/- mice than in wild-type controls. Since ADAM15 does not appear to be required for developmental angiogenesis or for adult homeostasis, it may represent a novel target for the design of inhibitors of pathological neovascularization.

UR - http://www.scopus.com/inward/record.url?scp=0041631044&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041631044&partnerID=8YFLogxK

U2 - 10.1128/MCB.23.16.5614-5624.2003

DO - 10.1128/MCB.23.16.5614-5624.2003

M3 - Article

VL - 23

SP - 5614

EP - 5624

JO - Molecular and Cellular Biology

JF - Molecular and Cellular Biology

SN - 0270-7306

IS - 16

ER -